Irit Gil-Ad
Inventor
Stats
- 16 US patents issued
- 26 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 16 US Patents Issued
- 26 US Applications Filed
- 243 Total Citation Count
- Feb 11, 2013 Most Recent Filing
- Sep 16, 2003 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
PERRIGO ISRAEL PHARMACEUTICALS LTD. | 1
1 1 | 2004
2005 2007 |
RAMOT AT TEL-AVIV UNIVERSITY LTD. | 1
3 1 4 9 1 4 6 4 4 3 | 2003
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 |
NOVAREMED LIMITED | 2
| 2012
|
BioLine RX Ltd. | 1
| 2007
|
BAR-ILAN UNIVERSITY | 2
4 6 4 6 4 4 1 | 2004
2006 2007 2009 2010 2011 2012 2013 |
BIOLINERX LTD. | 1
2 2 1 | 2006
2007 2011 2013 |
Inventor Addresses
Address | Duration |
---|---|
Herzeila, IL | Nov 04, 10 - Nov 04, 10 |
Herzelia, IL | Feb 12, 04 - Jan 20, 05 |
Herzlia, IL | Dec 02, 04 - Mar 10, 15 |
Herzliya, IL | Apr 15, 10 - Sep 09, 14 |
Petah Tiqwa, IL | Sep 18, 14 - Sep 15, 15 |
Technology Profile
Technology | Matters | |
---|---|---|
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 5 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 25 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 16 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
9133103 | 2015 | N-substituted benzenepropanamide and benzenepropenamide for use in the prevention or the treatment of affective disorders | 0 |
8975251 | 2015 | Methods of improving cognitive functions | 0 |
8916610 | 2014 | Acid addition salt of a nortriptyline-GABA conjugate and a process of preparing same | 0 |
2014/0275,273 | 2014 | N-Substituted Benzenepropanamide and Benzenepropenamide For Use in the Prevention or the Treatment of Affective Disorders | 0 |
8828993 | 2014 | Psychotropic agents having glutamate NMDA activity | 7 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.